01 1HAMARI PFST, Ltd.
01 1Chong Kun Dang Co., Ltd.
01 1Bushiramine
01 1Japan
Registrant Name : Chong Kun Dang Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-15-C-89-02
Manufacturer Name : HAMARI PFST, Ltd.
Manufacturer Address : 2-4300-18, Hachimampara, Yonezawa, Yamagata, 992-1128, Japan
54
PharmaCompass offers a list of Bucillamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bucillamine manufacturer or Bucillamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bucillamine manufacturer or Bucillamine supplier.
A Bucillamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bucillamine, including repackagers and relabelers. The FDA regulates Bucillamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bucillamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bucillamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Bucillamine supplier is an individual or a company that provides Bucillamine active pharmaceutical ingredient (API) or Bucillamine finished formulations upon request. The Bucillamine suppliers may include Bucillamine API manufacturers, exporters, distributors and traders.
click here to find a list of Bucillamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bucillamine Drug Master File in Korea (Bucillamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bucillamine. The MFDS reviews the Bucillamine KDMF as part of the drug registration process and uses the information provided in the Bucillamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bucillamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bucillamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bucillamine suppliers with KDMF on PharmaCompass.
We have 1 companies offering Bucillamine
Get in contact with the supplier of your choice:
